作为对抗固体癌症的微药品的CAR T细胞:在一阶段的工程过程中,结合效应T细胞介导的细胞死亡与血管向
Bianca Altvater1, Sareetha Kailayangiri1, Christian Spurny1
1Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.
Cancer gene therapy
|June 30, 2023
概括
这项研究设计了仿真抗原受体 (CAR) T 细胞以产生向蛋白质,通过诱导血管梗塞和低氧导致联合细胞死亡来增强它们对固体瘤的效力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 由于瘤的微环境,固体瘤对仿真抗原受体 (CAR) T 细胞疗法构成挑战.
- 提高CAR T细胞功效需要新的策略,将免疫媒介杀死与额外的治疗机制相结合.
研究的目的:
- 开发一种新的基于细胞的组合策略,以提高CAR T细胞在固体癌症中的疗效.
- 为了设计CAR T细胞作为微药房,产生向的促凝聚性融合蛋白,截断组织因子 (tTF) -NGR.
主要方法:
- 人类T细胞的单向量基因修饰以表达GD2特异性CAR和CAR诱导性tTF-NGR.
- 利用CAR T细胞向瘤血管内皮细胞输送tTF-NGR,诱导局部区域瘤血管梗塞.
- 评估GD2阳性瘤异端移植的小鼠模型中的治疗疗效.
主要成果:
- 改造的CAR T细胞表现出强大的GD2特异效应器功能,并以GD2依赖的方式分泌tTF-NGR.
- 与对照细胞相比,CAR T细胞透到瘤中并分泌tTF-NGR,显示出较高治疗活性的趋势.
- 试验室研究表明,T细胞细胞分解活性的低氧介导增强.
结论:
- 通过单向量工程将CAR T细胞向与额外的抗瘤机制相结合,是对固体癌症的一个有前途的战略.
- 这种方法利用CAR T细胞作为微药房来诱导血管梗塞和缺氧,导致免疫介导和缺氧结合的瘤细胞死亡.
- 这种新的方法在治疗固体瘤方面需要进一步发展.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
669
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.4K
相关概念视频
01:27Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Cytotoxic T Cells-mediated Immune Response
995
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
995
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
428
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
428